secwatch.observer — SEC 8-K summary
======================================

Issuer:     SHOULDER INNOVATIONS, INC. (SI)
CIK:        0001699350
Form:       8-K
Filed at:   2026-04-27T23:59:59+00:00
Accession:  0001699350-26-000021
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shoulder Innovations launches InSet I-135RFX Humeral Stem with expanded fracture indications
--------------------------------------------------------------------------------

- Full commercial launch of InSet I-135RFX Humeral Stem after limited market release and FDA 510(k) clearance for fracture indications.
- Product now indicated for primary, revision, and fracture total shoulder arthroplasty.
- Third addition to I-Series humeral stem line in three years, following InSet 95 (2024) and InSet 70 (2025).
- CEO Rob Ball says launch supports full spectrum of shoulder arthroplasty procedures.
- Built on InSet lateral-lateral implant philosophy shown to reduce complications and improve range of motion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699350/000169935026000021/0001699350-26-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699350/000169935026000021/si-20260427.htm
  HTML page:      https://secwatch.observer/filing/0001699350-26-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer